Skip to main content
Livermore
Livermore
ZHEN

AXA S.A.

SEC CIK
0000898427
Latest filing
Aug 14, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by AXA S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of NBIX by AXA S.A., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−5,789−100.0%Sold outHolders
Q1 20265,789$762.6K0.3%+5,789NewHolders
Q3 20250$00.0%−341,734−100.0%Sold outHolders
Q2 2025341,734$43.0M0.1%+8,035+2.4%AddedHolders
Q1 2025333,699$36.9M0.1%+35,995+12.1%AddedHolders
Q4 2024297,704$40.6M0.1%+28,532+10.6%AddedHolders
Q3 2024269,172$31.0M0.1%−14,850−5.2%ReducedHolders
Q2 2024284,022$39.1M0.1%+40,333+16.6%AddedHolders
Q1 2024243,689$33.6M0.1%+127,478+109.7%AddedHolders
Q4 2023116,211$15.3M<0.1%−2,718−2.3%ReducedHolders
Q3 2023118,929$13.4M<0.1%+31,664+36.3%AddedHolders
Q2 202387,265$8.23M<0.1%+35,604+68.9%AddedHolders
Q1 202351,661$5.23M<0.1%−19,158−27.1%ReducedHolders
Q4 202270,819$8.46M<0.1%−20,504−22.5%ReducedHolders
Q3 202291,323$9.70M<0.1%−16,947−15.7%ReducedHolders
Q2 2022108,270$10.6M<0.1%+49,602+84.5%AddedHolders
Q1 202258,668$5.50M<0.1%+58,668NewHolders
Q4 20210$00.0%−6,200−100.0%Sold outHolders
Q3 20216,200$595.0K<0.1%00.0%UnchangedHolders
Q2 20216,200$603.0K<0.1%+4,125+198.8%AddedHolders
Q1 20212,075$202.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.